Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary

5 Mar 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Mechanisms of cancer metastasis
Share to Ovarian cancer diagnosis and treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25744580
DOI: 10.1007/s10147-015-0811-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovaryPMID 25744580Read ↗

Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian CancersSemantic proximity Read ↗

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma.Semantic proximity Read ↗

Decreased ARID1A Expression Associates with Tumor Progression and Adverse Prognosis in Renal Cell CarcinomaSemantic proximity Read ↗

Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression.Semantic proximity Read ↗

ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosisSemantic proximity Read ↗

Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinomaSemantic proximity Read ↗

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell CarcinomaSemantic proximity Read ↗

ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer.Semantic proximity Read ↗

Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinomaSemantic proximity Read ↗

Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma.Semantic proximity Read ↗

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell CarcinomaSemantic proximity Read ↗

ARID1A in cancer: Friend or foe?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.